What dose of ramipril (generic) is equivalent to telmisartan 40 mg for hypertension management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Telmisartan 40 mg is Approximately Equivalent to Ramipril 5 mg

Based on the ONTARGET trial and guideline dosing tables, telmisartan 40 mg represents approximately 50% of the target dose (80 mg), which corresponds to ramipril 5 mg (50% of the 10 mg target dose). 12

Dose Equivalency Evidence

The 2020 ACC/AHA Heart Failure guidelines provide clear target dosing for both medications 1:

  • Telmisartan: Target dose 80 mg once daily; 50% of target = 40 mg
  • Ramipril: Target dose 10 mg once daily; 50% of target = 5 mg

This equivalency is supported by the landmark ONTARGET trial, which directly compared telmisartan 80 mg daily with ramipril 10 mg daily in 25,620 high-risk patients 233. The trial demonstrated:

  • Equivalent cardiovascular outcomes between the two doses (primary outcome occurred in 16.7% vs 16.5%, RR 1.01; 95% CI 0.94-1.09)
  • Similar blood pressure reductions, with telmisartan achieving only 0.9/0.6 mmHg lower BP than ramipril
  • Comparable mortality (RR 0.99; 95% CI 0.91-1.07)

Clinical Application

When converting between these medications for hypertension management:

  • Telmisartan 40 mg → Ramipril 5 mg (both represent 50% of target dose)
  • Telmisartan 80 mg → Ramipril 10 mg (both represent full target dose)

The FDA-approved dosing confirms this relationship 445:

  • Telmisartan starting dose: 40 mg once daily, titrate to 80 mg
  • Ramipril starting dose: 2.5 mg once daily, titrate to 10 mg (or 5 mg twice daily)

Important Caveats

Do not combine telmisartan with ramipril - the ONTARGET trial definitively showed that combination therapy (telmisartan 80 mg + ramipril 10 mg) provided no additional cardiovascular benefit but significantly increased adverse events, including syncope (0.3% vs 0.2%) and renal impairment (13.5% vs 10.2%) 26. The combination increased risk of dialysis, doubling of serum creatinine, or death (HR 1.09; 95% CI 1.01-1.18).

Titration considerations: While these doses are equivalent at steady state, ramipril requires more gradual titration due to higher risk of first-dose hypotension, particularly in volume-depleted patients 5. Start ramipril at 2.5 mg and increase over weeks, whereas telmisartan can often be initiated at 40 mg directly 4.

Related Questions

Is it appropriate to switch a patient from ramipril (Angiotensin-Converting Enzyme Inhibitor) 10mg daily to telmisartan (Angiotensin II Receptor Blocker) 40mg daily?
In a patient with subtle small vessel ischemic changes in the deep white matter on brain CT who has hypertension treated with telmisartan 5 mg, what pharmacologic therapy and dosages should be initiated?
How should I evaluate and manage a 52-year-old female (BMI ~34.6 kg/m²) with hypertension on telmisartan 40 mg daily and amlodipine 5 mg daily, presenting with a 2‑day history of generalized body aches, normal vital signs, normal TSH, normal serum calcium, normal uric acid, mild anemia (hemoglobin 11 g/dL) and HbA1c 5.2 %?
How should I evaluate and manage a 65-year-old female with hypertension on telmisartan 40 mg/amlodipine 5 mg daily who presents with a one‑week history of bilateral calcaneal pain and tenderness?
How should a 65-year-old woman with hypertension on telmisartan and amlodipine (once daily) who presents with fresh blood from the left external auditory canal after self‑insertion, with normal vital signs and an intact tympanic membrane, be managed?
What is an approximate calculation for VO2max?
What cognitive restructuring techniques can be used to reduce bedtime anxiety and improve sleep?
Do low red blood cell count, low hemoglobin, low hematocrit, borderline high red cell distribution width, and mildly elevated mean platelet volume indicate anemia?
In a patient with Parkinson's disease who experiences seizures, are seizures a typical feature and how should they be evaluated and managed?
Is it safe to give azithromycin and ondansetron together in an adult without known QT‑prolongation risk?
What is the recommended dosing frequency of cephalexin for impetigo versus skin and soft tissue infections?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.